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Like other mucosal surfaces (e.g., the gastrointestinal tract, the respiratory tract), the
human female reproductive tract acts as an initial barrier to foreign antigens. In this role,
the epithelial surface and subepithelial immune cells must balance protection against
pathogenic insults against harmful inflammatory reactions and acceptance of particular
foreign antigens. Two common examples of these acceptable foreign antigens are the
fetal allograft and human semen/sperm. Both are purposely deposited into the female
genital tract and appropriate immunologic response to these non-self antigens is essential
to the survival of the species. In light of the weight of this task, it is not surprising
that multiple, redundant and overlapping mechanisms are involved. For instance, cells
at the immunologic interface between self (female reproductive tract epithelium) and
non-self (placental trophoblast cells or human sperm) express glycosylation patterns
that mimic those on many metastatic cancer cells and successful pathogens. The
cytokine/chemokine milieu at this interface is altered through endocrine and immunologic
mechanisms to favor tolerance of non-self. The “foreign” cells themselves also play an
integral role in their own immunologic acceptance, since sperm and placental trophoblast
cells are unusual and unique in their antigen presenting molecule expression patterns.
Here, we will discuss these and other mechanisms that allow the human female
reproductive tract to perform this delicate and indispensible balancing act.
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INTRODUCTION
There are specific locations in human tissues and organs where
alloantigens and autoantigens are tolerated by the immune sys-
tem. This tolerance can exist indefinitely or for defined periods
of time like pregnancy. This uncoupling of the adaptive immune
response confers a physiological state known as immune privilege
(Streilein, 1995). Evidence suggesting the existence of immune
privilege was first obtained by van Dooremal, who documented
the extended survival of murine skin xenografts in the anterior
chamber of the dog eye in 1873 (van Dooremaal, 1873). Other
well-established immune privileged tissues and organs include
the uteroplacental unit (Medawar, 1953; Beer and Billingham,
1971), brain (Muldoon et al., 2013), testes (Li et al., 2012), and
the prostate (Neaves and Billingham, 1979; Leibovitz et al., 2004).
Peter Medawar initially recognized that the mammalian fetus
is an allograft due to the contribution of its foreign paternal
alloantigens (Medawar, 1953). Unrelated surrogate mothers read-
ily accommodate a completely foreign fetus as well as their own
offspring, confirming that maternal histocompatibility is unnec-
essary. These observations indicate that the female reproductive
tract is immune privileged during pregnancy. However, a sexu-
ally active woman’s immune components must respond robustly
to pathogens at all times, yet remain selectively tolerant to male-
associated antigens present in human seminal plasma and sperm.
The goal of this review is to consider the current evidence
describing how immune privilege is manifested in the female
reproductive tract during pregnancy and semen exposure, both
of which should otherwise provoke potent immune responses.
IMMUNE PRIVILEGE DURING PREGNANCY
THE HUMAN ZONA PELLUCIDA (ZP)
The mammalian egg is surrounded by the zona pellucida (ZP),
which acts as a specialized extracellular matrix for binding sperm.
For fertilization to occur, sperm must first bind to this matrix,
transit through this barrier and fuse with the egg cell to form
a zygote (Clark, 2010). The zygote is an equal combination of
both the maternal and foreign paternal genomes. It is unknown
at which stage the human pre-embryo begins to express pater-
nal major histocompatibility (MHC) molecules. However, in the
mouse, MHC expression is readily detected at the eight cell stage
(Ewoldsen et al., 1987). Cytotoxic T lymphocyte cells (CTL)
sensitized to paternal MHC antigens are unable to kill mouse pre-
embryos surrounded by an intact ZP, but pre-embryos denuded
of this matrix are immediately destroyed (Ewoldsen et al., 1987).
The ZP has been suggested to simply act as a physical barrier
against the rejection of the human pre-embryo (Ewoldsen et al.,
1987). However, many types of immune cells transit through sim-
ilar types of physical barriers during the rejection of a foreign
organ transplant (Krensky et al., 1990). Human ZP glycopro-
teins express N-glycans terminated with multivalent sialyl-Lewisx
sequences (SLEX) that mediate sperm binding (Figure 1) (Pang
et al., 2011). SLEX is also the universal ligand for the selectins,
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FIGURE 1 | Carbohydrate sequences involved in immune privilege in
the human reproductive system. N-glycans usually have two
(biantennary), three (triantennary), or four (tetraantennary) antennae linked
at up to four positions (designated A–D). On the human ZP, there are
biantennary and triantennary N-glycans terminated on every antenna with
the SLEX sequences on every antenna (Pang et al., 2011). Tetraantennary
N-glycans bearing three SLEX antenna are also present. Human sperm
and seminal plasma express bi-, tri-, and tetra-antennary N-glycans
terminated exclusively with Lewisx or exclusively with Lewisy sequences
on their antennae, though many carry a mixture of both of these
sequences (Pang et al., 2007, 2009). Glycodelin-A bears the fucosylated
lacdiNAc sequence on 60% of its total N-glycans (Dell et al., 1995).
Uromodulin expresses one (UM-1), two (UM-2), or three SLEX
sequences on a single O-glycan (Easton et al., 2000). These types of
presentations have not been found in other normal cells or tissues
outside of the human reproductive system.
cell adhesion molecules that mediate both the binding of immune
cells to inflamed vascular endothelium and lymphocyte hom-
ing (Foxall et al., 1992; Fukuda et al., 1999). SLEX is also a
ligand for siglec-9, an immunoglobulin-like lectin that carries
an immunoreceptor tyrosine-based inhibitory motif (ITIM) that
generates an inhibitory signal in several immune cell populations
(Angata and Varki, 2000; Avril et al., 2004). The possibility has
been raised that the carbohydrate sequences expressed on the ZP
act as functional groups to protect the early pre-embryo before
blastocyst hatching (Clark et al., 1996, 1997). In short, the human
egg itself could be an immune privileged cell type both before and
after fertilization.
GLYCODELIN-A (Gda) AND CA125
When the histoincompatible human pre-embryo hatches out of
the blastocyst, it faces the daunting task of invading the maternal
endometrial lining where four major immune cell populations
are present: uterine NK cells (uNK), macrophages, T cells, and
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dendritic cells (DC) (King et al., 1998; Tirado-Gonzalez et al.,
2012). During the early stages of implantation, trophoblast cells
secrete the chemokine MIP-1α that induces uNK cells and mono-
cytes to migrate to the implantation site, resulting in the for-
mation of a dense infiltrate of these cells in the decidua basalis
(Drake et al., 2001). It is apparent that the implanting human
embryo is challenged at an early stage by these immune cells. One
major question becomes apparent: how does the encircled human
embryo resist challenge by these immune cells at this early stage?
Glycodelin-A (GdA) (PP14) is a luteal phase endometrial gly-
coprotein that is secreted beginning 2 days after ovulation (Dalton
et al., 1995). This 27 kDa glycoprotein manifests many different
immune deviating effects when present at physiological concen-
trations in vitro (Table 1). If implantation succeeds, the synthesis
of GdA is massively induced, becoming 4–16% of the total pro-
tein content expressed in early stage decidua (7–11 weeks of
pregnancy) (Julkunen et al., 1985). GdA is also taken up by the
placenta and concentrated in this organ. This glycoprotein is
also present in physiologically relevant concentrations in amni-
otic fluid, reaching levels averaging 46μg/ml between 12 and 20
weeks (Julkunen et al., 1985). However, the level of GdA decreases
dramatically after 20 weeks, becoming a minor component of
decidual proteins and the amniotic fluid at term.
Glycodelin has also been isolated from seminal plasma and
has been designated GdS. Its protein backbone is identical to
GdA, but GdS does not cause the diverse immunomodulatory
effects associated with GdA. Instead, in vitro studies indicate that
it blocks the capacitation of human sperm (Chiu et al., 2005).
Biophysical analyses of GdA and GdS confirm major differences
in their N-glycosylation patterns. GdA expresses very unusual
fucosylated lacdiNAc and Sda sequences on the antennae of its
N-glycans; these are completely lacking in GdS (Morris et al.,
Table 1 | Immunomodulatory activities of Glycodelin-A.
Effect References
Inhibits T cell proliferation by PHA and
other activators
Pockley et al., 1988
Decreases production of IL-2 following
T cell activation
Pockley and Bolton, 1989
Induces apoptosis of activated T cells Mukhopadhyay et al., 2001
Binds CD45 on T cells via a potential
lectin-like activity
Ish-Shalom et al., 2006
Inhibits lysis of K562 target cells by large
granular lymphocytes
Okamoto et al., 1991
Diminishes IgM secretion and MHC class II
expression in B cells
Yaniv et al., 2003
Blocks chemoattractant induced migration
of monocytes
Mukhopadhyay et al., 2001
Inhibitor of E-selectin-mediated cell
adhesion
Jeschke et al., 2003
Stimulates IL-6 secretion by monocytes/
macrophages via interaction with L-selectin
and the extracellular signal regulated kinase
pathway
Lee et al., 2012
1996; Lee et al., 2009). The fucosylated lacdiNAc sequence is a car-
bohydrate ligand for both selectins and DC-SIGN, two immune
lectins that have been implicated in leukocyte/lymphocyte bind-
ing and the modulation of the adaptive immune response,
respectively (Grinnell et al., 1994; van Liempt et al., 2006). The
carbohydrate sequences linked to GdA have been implicated as
functional groups that enable this glycoprotein to mediate its
immunomodulatory effects (Clark et al., 1996, 1997).
CA125 (MUC 16) is the largest mucinous glycoprotein in the
human genome, coding for ∼24,000 amino acids (Yin et al.,
2002). It is best known for its role as a specific marker for epithe-
lial ovarian cancer (Bast et al., 1981, 1983). CA125 isolated from
the human ovarian cancer cell line, OVCAR-3, is heavily N- and
O-glycosylated, and its constituent glycans have been sequenced
(Kui Wong et al., 2003). CA125 is secreted by endometrial epithe-
lial cells during the same temporal window of the menstrual cycle
as GdA (Kui Wong et al., 2003). Like GdA, this mucinous gly-
coprotein also becomes a major secreted product during the first
trimester of human pregnancy. CA125 derived from OVCAR-3
cells suppresses cytotoxicity mediated by NK and lymphokine
activated killer cells (LAK) in vitro when present at the physiolog-
ical concentrations seen in the endometrium and decidua during
the first trimester of pregnancy (Patankar et al., 2005). CA125
manifests this specific effect by blocking NK cell synapse forma-
tion, which results in the direct inhibition of NK cell mediated
cytotoxicity (Gubbels et al., 2010).
In summary, GdA and CA125 likely participate in suppressing
the maternal immune responses before implantation and con-
tinue to do so until mid-trimester. Defective expression of these
glycoproteins during this stage of pregnancy would likely result
in implantation failure or early pregnancy loss. However, whether
defective expression of these modulators sets the stage for other
pathological processes that are manifested after midtrimester is
currently unknown.
DIFFERENTIAL EXPRESSION OF HUMAN MAJOR HISTOCOMPATIBILITY
(MHC) ANTIGENS
The human leukocyte antigen (HLA) region of human chro-
mosome 6 encodes many immune system genes, including the
MHC complex class I and II molecules, which can be found
on the surface of almost all nucleated cell types. HLA expres-
sion is tightly regulated at the feto-maternal interface, perhaps
because direct engagement of foreign paternal or maternal anti-
gens could trigger fetal rejection. When the human embryo first
makes contact with the maternal endometrial epithelium, placen-
tal trophoblast cells at the adhesion site fuse and form a syncytium
of multinucleated cells called syncytiotrophoblast (SynT) cells.
Unlike normal cells and tissues, SynT and the underlying vil-
lous cytotrophoblasts (CytoT) do not express HLA class I and
class II molecules (Hutter et al., 1996). This unusual characteristic
ensures that paternal HLA antigens that could trigger histocom-
patibility based immune rejection are not expressed on these
invasive trophoblast populations.
This lack of HLA expression, however, is somewhat prob-
lematic from an immunological perspective. About 70% of the
immune cells at the implantation site during the early stages of
pregnancy are uNK cells (King et al., 1996). Though not as potent
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in this activity as peripheral NK cells, uNK cells lyse HLA nega-
tive cells based on the “missing self” hypothesis (King et al., 1989;
Karre, 1991). Currently, there is no explanation for how SynT
resist these NK cell-mediated responses, since they are some-
what sensitive to lymphokine activated killing (King and Loke,
1990). However, there are large amounts of GdA andCA125 in the
uterus during implantation that could substantially affect uNK
cell mediated cytotoxicity.
Further complexity in this system is added by the expression
of uncommon HLA class I molecules on specific, highly-invasive
trophoblast cell subpopulations. The placental villi are a com-
plex series of branching structures that contain a core of fetal
vessels surrounded by stroma (Figure 2). Separating the stroma
and fetal vessels from the maternal blood present in the spaces
between villous structures are an inner, non-continuous layer of
villous cytotrophoblast cells (CytoT) and an outer, continuous
layer of fused, multinuclear SynT cells (Georgiades et al., 2002).
Some placental villae float freely in the intervillous space, while
others traverse the space to attach or anchor themselves to the
maternal decidualized endometrium (decidua). The third tro-
phoblast cell type, extravillous cytotrophoblast (EVTB) cells arise
at the tips of anchoring villae and invade deeply into the mater-
nal decidua (Benirschke, 1994). Invasion in humans typically
extends into the inner third of the uterine muscle (myometrium).
EVTB also invade the maternal uterine vessels, called spiral arter-
ies due to their anatomic appearance. EVTB plug maternal spiral
arteries until approximately 10 weeks of pregnancy (Burton and
Jauniaux, 2004) and remodel the vessel walls to convert them
from highly vasoactive structures into relatively unresponsive
conduits for blood flow from mother to baby. After 10 weeks of
gestation, EVTB vascular plugs disappear to allow unobstructed
flow through these conduits (Meekins et al., 1997).
EVTB are unlike all other human cells in their MHC class I
expression. HLA-G and HLA-E are MHC class Ib molecules
with restricted polymorphism that can be detected on the sur-
face of EVTB (Juch et al., 2012). uNK cells bear inhibitory
killer immunoglobulin-like receptors (KIR) that specifically rec-
ognize these molecules. HLA-E binds to CD94/NKG2A (King
et al., 2000), whereas HLA-G binds to KIR2DL4 (Rajagopalan and
Long, 1999). EVTB also express HLA-C, which is a polymorphic
MHC class I molecule like HLA-A and HLA-B and could—
but does not appear to—strongly stimulate harmful antipater-
nal adaptive immune responses (Chazara et al., 2011). HLA-C
molecules also specifically bind to NK cell KIRs.
OTHER IMMUNOLOGICAL ACTIVITIES OF HLA-G
Currently, seven different isoforms of HLA-G, designated G1–G7,
have been identified. HLA-G1, -G2, -G3 and -G4 are membrane-
associated forms whereas HLA-G5, -G6 and -G7 (Figure 3) are
soluble forms (Favier et al., 2007b). Both soluble and membrane
associated forms of HLA-G can induce many immunomodula-
tory effects in vitro (Hunt, 2006; Favier et al., 2007b). These
include: (1) inhibition of NK cell-mediated responses by either
soluble or cell surface associated forms; (2) abrogation of the
lytic activity mediated by CTLs via either soluble or membrane
bound isoforms; (3) suppression of the IFN-γ mediated upregu-
lation of CD8α mRNA by recombinant soluble forms of HLA-G1
and HLA-G2; (4) inhibition of the alloproliferative responses
of CD4+ T cells as a membrane-bound molecule expressed by
third party inert cells or by cells presenting a stimulating antigen;
FIGURE 2 | Human placental structure (after 12 weeks of gestation): the
human placenta has a fetal and a maternal side. The fetal side consists of
a mass of tree-like villous structures that are bathed in maternal blood. Unlike
floating villae, anchoring villae traverse the blood-filled intervillous space and
attach to the maternal decidualized endometrium. The maternal decidua is
populated by stromal and immune cells and is crossed by spiral arteries that
dump blood into the intervillous space. Floating and anchoring placental villae
are coated by an inner layer of individual, fetally-derived cytotrophoblast
(Cyto-T) cells and an outer layer of fused syncytiotrophoblast (Syn-T) cells. A
third population of fetally-derived trophoblast cells arises from Cyto-T at the
tips of anchoring villae. These extravilous cytotrophoblast (EVTB) cells invade
deeply into the maternal tissues and remodel maternal spiral arteries.
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FIGURE 3 | HLA-G: the most common form of the non-classical
MHC class Ib molecule, HLA-G, mimics HLA-A and -B in structure
and is called HLA-G1. HLA-A, -B and -G1 are all homodimers of an
MHC class I heavy chain comprised of five domains and a stabilizing
second molecule, beta-2 microglobulin (β2m). The MHC class I heavy
chain consists of an α1 and α2 domain (forming the antigenic
peptide-binding groove), an α3 domain, a transmembrane domain and a
cytopalasmic tail. Unlike classical MHC class I molecules, the
cytoplasmic tail of HLA-G is very short, containing only six amino
acids. Also unlike classical MHC class Ia molecules, HLA-G can be
detected as several spliced variants. The most common of these are
the membrane-bound HLA-G1, -G2, -G3 and -G4 and the soluble
HLA-G5, -G6 and -G7. Soluble forms have lost their transmembrane
segments and cytoplasmic tails during splicing.
(5) induction of the differentiation of Tregs by stimulating
antigen-producing cells; and (6) disruption of DC maturation.
These effects are mediated through direct binding to inhibitory
receptors designated immunoglobulin-like transcript-2 and -4
(ILT2, ILT4) and the KIR, KIR2DL4 (Favier et al., 2007a). ILT2 is
expressed by both myeloid and lymphoid cells. ILT4 is exclusively
expressed by myeloid cells and KIR2DL4 is expressed by NK and
some T cells bearing CD81.
The effects of HLA-G in vitro are quite varied and affect many
different types of potential immune responses in the pregnant
uterus. However, the exact protein levels of the soluble and cell
surface-associated isoforms of HLA-G in the fetoplacental unit
and in the maternal decidua and periphery have yet to be deter-
mined. There also remain questions about HLA-G expression in
different physiological states, including the proposal that the sol-
uble forms of HLA-G (HLA-G5, -G6, and -G7) are not present in
the pregnant uterus at all (Blaschitz et al., 2005; Sargent, 2005).
In fact, the functions of HLA-G during the early human implan-
tation have been difficult to definitively establish. Specifically,
decidual NK (dNK) cells do not reproducibly express KIR2DL4
and the interaction between this KIR and HLA-G has not been
consistently demonstrated (Apps et al., 2008). In addition, Moffet
et al. have recently shown that HLA-G has no effect on freshly iso-
lated human dNK cells in several functional tests that are known
to greatly affect peripheral blood NK cells (Apps et al., 2011).
REGULATORY T CELLS (TREGS)
Tregs are essential for the development of immune privilege in
the uterus during early but not late mouse pregnancy (Aluvihare
et al., 2004; Shima et al., 2010). In humans, these cells have
a specific phenotype (CD4+CD25+FoxP3+) and accumulate in
the endometrium during the follicular phase of the menstrual
cycle (Arruvito et al., 2007). These numbers are maintained if
implantation proceeds, but otherwise decrease dramatically in the
luteal phase. A decrease in the number of decidual Tregs during
early pregnancy in women is correlated with spontaneous abor-
tions (Sasaki et al., 2004). Tregs decrease the cytolytic activity of
NK cells (Ghiringhelli et al., 2006), impede the development of
DCs (Bluestone and Tang, 2005) and negatively impact the pro-
liferation of and cytokine release by CD3+ T cells (Earle et al.,
2005).
GALECTINS
Galectins are a family of small lectin molecules that generally have
a universal affinity for N-acetyllactosamine (galactose in β1-4
linkage to N-acetylglucosamine; Galβ1-4GlcNAc) but which can,
in some cases, bind to other carbohydrate sequences (Barondes
et al., 1994). For example, several galectins, including galectin-3,
also bind to the Thomsen–Friedenreich (T–F) antigen (Galβ1-
3GalNAc) (Bian et al., 2011). In 1983, placental protein 13 was the
first galectin isolated from the female reproductive tract (Bohn
et al., 1983). Galectin-1 is another major galectin that is found in
villous CytoT. This galectin has been reported to induce T cell
apoptosis (Perillo et al., 1995), although there is some debate
about whether this effect was due to non-physiological incuba-
tion conditions (Stowell et al., 2007). Nonetheless, interest in
the expression of human placental galectins increased substan-
tially when galectin-1 deficient mice in a stress-induced model
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of pregnancy failure were reported to display higher rates of fetal
loss than control mice (Blois et al., 2007). These investigators also
demonstrated that this effect could be completely reversed by the
administration of recombinant galectin-1. Galectin-1 has been
proposed to mediate its effects via a variety of different mecha-
nisms including: (1) differentially regulating the survival of Th
cell subsets (Toscano et al., 2007; Motran et al., 2008); (2) con-
trolling T cell trafficking (He and Baum, 2006; Norling et al.,
2008); and (3) promoting the differentiation of tolerogenic DCs
(Ilarregui et al., 2009; Kuo et al., 2011). In one recent study, com-
pelling evidence was provided that suggests the overall serum
level of galectin-1 is decreased dramatically (eight-fold) in spon-
taneous abortion patients when compared to normal pregnant
controls (Tirado-Gonzalez et al., 2013).
INDOLEAMINE 2,3-DIOXYGENASE (IDO)
Indoleamine 2,3-dioxygenase (IDO) is an enzyme that can be
induced in specific macrophages following their stimulation
with IFN-γ and other mediators (Munn and Armstrong, 1993).
Activation of this enzyme inhibits T cell-mediated responses by
catabolizing the tryptophan that is essential for normal T cell
proliferation. IDO is also synthesized by human Syn-T isolated
from fresh placenta (Kamimura et al., 1991). Based on these
effects, this enzyme was proposed to be a major mediator of
immune tolerance during pregnancy. To test this hypothesis,
Munn et al. exposed pregnant mice carrying either syngeneic
or allogeneic fetuses to 1-methyl-tryptophan, a pharmacologic
agent that inhibits IDO activity (Munn et al., 1998). Pregnant
mice treated with this agent accommodated syngeneic but not
allogeneic pups, suggesting IDO mediated tolerance. However,
matings of male and female IDO-deficient mice generate lit-
ters of normal size, suggesting that the expression of IDO is
not absolutely obligatory for mouse reproduction (Baban et al.,
2004). Nonetheless, IDO likely plays a complementary role to
other pregnancy-specific factors that insure the suppression of
responses against the semiallogeneic fetus.
UROMODULIN
Tamm–Horsfall glycoprotein (THP) is the major pro-
tein/glycoprotein component in human urine (Tamm and
Horsfall, 1950). Uromodulin is a differentially glycosylated form
of THP that is present in the urine of pregnant human females,
but not human males or non-pregnant females (Easton et al.,
2000). It is 13 times more potent in the inhibition of antigen-
induced T cell proliferation in vitro than THP derived from
non-pregnant females and males (Hession et al., 1987). Rigorous
analysis of uromodulin-derived oligosaccharides revealed the
presence of unusual core 2 type O-glycans terminated with up
to three SLEX terminals (Easton et al., 2000). By comparison,
THP from non-pregnant females and males expresses very simple
mono- and di-sialylated derivatives of Core 1 O-glycans, indicat-
ing a dramatic remodeling of THP glycosylation. Analysis of THP
O-glycans isolated from females 2 months postpartum revealed
a near total loss of SLEX modifications and a reversion back to
forms that characterize the non-pregnant state. This observation
suggests that uromodulin expression relies on human pregnancy
hormones (e.g., estrogens, progesterone) or other related factors.
How uromodulin contributes to the maintenance of immune
privilege during pregnancy remains an enigma.
IMMUNE PRIVILEGE FOR SEMEN AND SPERM IN THE
FEMALE REPRODUCTIVE TRACT
The immune system in the human female reproductive tract
is also challenged by both the cellular and soluble compo-
nents of human semen. The vagina and the cervix represent
a relatively hostile environment for human sperm (Drobnis
and Overstreet, 1992). Soon after sexual intercourse, mater-
nal neutrophils, monocytes, and lymphocytes are released from
the cervical epithelium during a cellular response known as
the leukocyte reaction (Pandya and Cohen, 1985; Thompson
et al., 1992). Human sperm do not express paternal MHC
class I or II molecules on their surface and should not trig-
ger histocompatibility-based responses (Hutter and Dohr, 1998).
However, immature germ cells, epithelial cells, and leukocytes
are present in semen, although they usually comprise less than
15% of the total cellular fraction (Fedder, 1996). Unlike sperm,
these cells express paternal MHC molecules that could stimulate
an MHC-restricted response at the surface of the cervico-vaginal
epithelium (Zinkernagel and Doherty, 1974).
Sperm arise from testicular germ cells after the commence-
ment of puberty and long after the period of thymic education
(Fijak and Meinhardt, 2006). Proteins that are unique to human
sperm are therefore foreign to the immune system and could
be classified as either autoantigens or neoantigens. Evidence
favoring this categorization includes the known induction of
autoimmune orchitis following the autologous injection of tes-
ticular homogenates at sites distal to the testes (Tung et al.,
1981). However, allografts and xenografts resist rejection follow-
ing transplantation into the testis itself (Head and Billingham,
1985). This immune privileged state was initially thought to be
due to the presence of a blood-testis barrier that protected germ
cells from immune effector cells and antibodies (Setchell, 1967;
Dym, 1973). Arguing against this paradigm is the fact that germ
cell neoantigens on spermatogonia and early spermatocytes can
be found in the basal compartments of the testis, which lack the
blood-testis barrier (Yule et al., 1988; Saari et al., 1996). Further,
neoantigens can also be detected in seminal plasma, which con-
tains components that are produced by several glands in the male
urogenital tract (Gupta et al., 1988).
Many of the known sperm and seminal plasma neoantigens
are produced in response to androgen stimulation. While these
antigens should provoke a potent immune response in the female
reproductive system, the incidence of women with antisperm
antibodies is only 2–3%.When antibodies are produced, however,
subfertility or infertility often follows (Rumke andHellinga, 1959;
Lombardo et al., 2001). Allergic reactions to the fluid components
of seminal plasma are also rare (Sublett and Bernstein, 2011).
These results suggest that powerful immune-deviating effects are
in play within the female genital tract.
Based on the excellent outcomes of IVF and artificial insem-
ination procedures, which separate germ cells from seminal
plasma, it is apparent that seminal plasma components are not
required for successful fertilization. On the other hand, exposure
to seminal plasma may be crucial to reductions in certain disease
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states in humans. Preeclampsia is a common but incompletely
understood complication of pregnancy with pleomorphic patho-
logical effects (Pennington et al., 2012). Interestingly, women
who have had prolonged exposure to semen via unprotected oral
or vaginal sex exhibit a considerably lower risk of developing
preeclampsia than women who have had a much more limited
duration of semen exposure (Basso et al., 2001; Kho et al., 2009).
These results lead to the conclusion that seminal plasma sup-
presses specific immune responses in the female reproductive
tract and, in several instances, tolerizes the female to paternal
immune challenges. The net effect would be to protect the female
from other immune-related disease states of pregnancy. Several
factors in seminal plasma have been proposed to be responsible
for this immune deviation.
PROSTAGLANDINS
Human seminal plasma contains very high concentrations of
prostaglandins when compared to other bodily secretions. These
bioactive compounds were initially independently identified in
this fluid by von Euler and Goldblatt in 1935 (Goldblatt, 1935;
von Euler, 1935, 1936). Prostaglandin E1, E2, E3, F1α, and F2α
have been detected in human seminal plasma (Samuelsson, 1963).
It is now apparent that PGE2, 19-hydroxyprostaglandin E1 and
19-hydroxyprostaglandin E2 are the three major prostaglandins
in human seminal plasma, each being present in millimolar con-
centrations (Taylor and Kelly, 1974; Kelly et al., 1976; Templeton
et al., 1978). Since these lipid mediators often manifest their
effects in the μM to nM concentration range, virtually all path-
ways that are affected by these lipids are operating under saturat-
ing conditions in human semen.
PGE2 is a potent modulator of immune function. The effects
of PGE2 have been the subject of intense investigation for over 20
years because of its association with cancer and other patholog-
ical states. This prostaglandin can simultaneously manifest both
proinflammatory and immunosuppressive effects. These effects
are summarized with references in Table 2.
The overall effects of PGE2 include: (1) inhibition of responses
mediated by phagocytic cells (neutrophils, macrophages); (2)
suppression of NK, CTL, and T helper type 1 responses; (3)
activation of DCs but limitation of their ability to attract naïve,
memory, and effector T cells; and (4) stimulation of the produc-
tion of regulatory T cells and myeloid-derived suppressor cells.
In summary, the effects of PGE2 are consistent with a role in
the inhibition of antigen-driven Th1 responses and in the pro-
motion of Th2 responses. This overall response is essentially that
which would be necessary to suppress responses directed against
neoantigens while simultaneously maintaining the effectiveness
of select beneficial immune responses.
CYTOKINE EXPRESSION
Human seminal plasma contains substantial amounts of a potent
immunoregulatory cytokine known as transforming growth
factor-β (TGF-β) (Nocera and Chu, 1993), although only∼7% of
TGF-β in seminal plasma is in the active form (Nocera and Chu,
1995). Latent TGF-β can be activated by acidic conditions (tran-
sient acidification to pH 3.2) (Wakefield et al., 1987). Still, even
though the healthy vaginal environment is acidic at baseline, it is
unlikely that a significant amount of TGF-β is activated here after
deposition in the vagina because the buffering capacity of the rel-
atively large volume of basic human seminal plasma causes the
pH of the vaginal environment to increase from 4.3 to 7.2 within
8 s after ejaculation (Fox et al., 1973).
The levels of other cytokines in human seminal plasma have
also been studied (Maegawa et al., 2002). The levels of IL-1α,
IL-2, IL-4, IL-6, IL-8, TNF-α, interferon-γ, granulocyte colony-
stimulating factor [G-CSF] and macrophage CFS [M-CSF] have
been analyzed. The pro-inflammatory cytokines (IL-1α, TNF-α),
chemokine (IL-8) and G-CSF are present, but at low levels. The
remainder are undetectable. In short, the levels of inflammatory
cytokines in the lower female genital tract are very low under
normal physiological conditions.
Very elegant, but difficult to perform investigations have been
conducted to assess the effects of seminal plasma on cytokine
expression in the human cervix. Twelve hours after unprotected
vaginal intercourse with ejaculation, the mRNA levels for colony
stimulating factor 2, IL-6. IL-8 and IL-1α in human cervical
biopsies are enhanced when compared to controls (abstention or
condom-protected controls) (Sharkey et al., 2012b). Seminal fluid
not only induces the expression of pro-inflammatory cytokines
and chemokines in the cervix, but also causes a major influx of
macrophages, DCs, and memory T cells (Sharkey et al., 2012b).
Still, TGF-β has been the component of seminal plasma most
directly implicated in this response (Sharkey et al., 2012a).
UNUSUAL GLYCOSYLATION OF HUMAN SPERM AND SEMINAL
PLASMA GLYCOPROTEINS
The role of glycosylation in inducing immune privilege, par-
ticularly in the reproductive tract, has been understudied.
Historically, carbohydrate ligands and their complementary
lectin-like immune receptors have been difficult to isolate and
characterize. However, the development of ultrasensitive mass
spectrometric (MS) techniques for sequencing oligosaccharides,
when combined with the use of glycan arrays to define carbo-
hydrate binding specificities, have recently changed the research
landscape in this area (Blixt et al., 2004; North et al., 2009). The
molecular bases underlying the ability of specific carbohydrate
sequences to act as functional groups that suppress immune func-
tion are now being revealed and previous predictions about these
relationships are being validated (Clark et al., 1996, 1997).
Ultrasensitive MS profiling of the N-glycans associated with
human sperm and seminal plasma has uncovered the expression
of unusual glycans (Pang et al., 2007, 2009). A distinguishing
feature of these glycans is the presence of Lewisx and Lewisy
sequences that are rarely found on the oligosaccharides present
on the surface of other normal cell and tissue types outside
of the male reproductive system. These sequences are displayed
in multivalent presentations on the terminal ends of bianten-
nary, triantennary, and tetraantennary N-glycans (Figure 1). The
N-glycans linked to the human ZP are similar, except that they are
terminated with multivalent SLEX rather than Lewisx or Lewisy
sequences (Pang et al., 2011).
The endogenous glycoprotein ligands for immune type lectins
have been proposed to be the true mediators of immune
homeostasis (Garcia-Vallejo and van Kooyk, 2009). There are four
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Table 2 | Effects of PGE2 on immune function.
Immunological effects References
Inhibits granulocyte functions Smith, 1977
Limits the phagocytic activity of alveolar macrophages and their pathogen killing
function
Hubbard et al., 2010
Promotes the tissue influx of neutrophils, macrophages, and mast cells Yu and Chadee, 1998; Nakayama et al., 2006; Weller et al., 2007
Converts DCs to myeloid derived suppressor cells Obermajer et al., 2011
Suppresses NK cell mediated cytotoxicity Bankhurst, 1982; Goto et al., 1983
Inhibits NK cell responses to IL-12, IL-15, and IL-2 Joshi et al., 2001; Walker and Rotondo, 2004
Blocks NK cell production of IFN-γ, inhibiting NK cell helper function Mailliard et al., 2005
Disrupts early stages of differentiation of dendritic cells (DCs) Kalin´ski et al., 1997
Promotes the induction of mast cells and their local attraction and degranulation Hu et al., 1995; Gomi et al., 2000
Directly inhibits T cell production of IL-2 and IL-2 responsiveness Walker et al., 1983
Enhances the production of Th2-attracting chemokines McIlroy et al., 2006
Supports the induction of fully mature DCs Jonuleit et al., 1997
Accelerates DC maturation and elevates their costimululatory molecules when
present in combination with IL-1β and TNF-α
Rieser et al., 1997; Kalin´ski et al., 1998
Promotes the expression of CCR7, the receptor for chemokines L19 and L20 in
monocyte-derived DCs
Luft et al., 2002; Scandella et al., 2002
Inhibits early stages of B cell activation and Ig class switching Simkin et al., 1987
Limits migration of DCs via induction of tissue inhibitor of proteinase-1 Baratelli et al., 2004
Increases the expression of IL-10, thrombospondin and IDO in DCs Kalin´ski et al., 1997; Doyen et al., 2003; Braun et al., 2005
Promotes the maturation of DCs with an impaired ability to induce CTL-, Th1- and
NK cell-mediated type 1 immunity
Kalin´ski et al., 1998, 1999; Gustafsson et al., 2008
Suppresses the level of bioactive IL-12p70 Kalin´ski et al., 1998
Blocks the ability of DCs to attract naïve T cells Muthuswamy et al., 2010
Suppresses the production of IL-12 in monocytes and DCs van der Pouw Kraan et al., 1995; Kalin´ski et al., 1997, 1998
Blocks the expression of the IL-12 receptor in monocytes and DCs Wu et al., 1998
Promotes the development of IL-17 producing T cells Sheibanie et al., 2007; Woolard et al., 2008; Boniface et al., 2009;
Esaki et al., 2010
Inhibits cytotoxic T lymphocyte (CTL) activity Lala et al., 1988; Parhar and Lala, 1988; Specht et al., 2001
Blocks activation of CTL responses by DCs by inhibiting IL-12 secretion Watchmaker et al., 2010
Promotes IgE production Carini et al., 1981
Promotes the development of regulatory T cells Baratelli et al., 2005; Bergmann et al., 2007
Promotes the interaction of DCs with regulatory T cells Muthuswamy et al., 2008
Required for the development of tumor associated suppressive macrophages and
myeloid-derived suppressor cells
Heusinkveld et al., 2011; Obermajer et al., 2011
Induces the expression of IL-10 in tissue macrophages Huang et al., 1998; Stolina et al., 2000
Suppress the production of retinoic acid in gut-associated DCs Stock et al., 2011
major glycoproteins in human seminal plasma that have been
identified as endogenous ligands for DC-SIGN, an immune lectin
associated with DCs. They include clusterin, galectin-3 bind-
ing protein, prostatic acid phosphatase, and protein C inhibitor
(Clark et al., 2012). The exact function of these glycoproteins
remains to be determined, but studies with parasites and other
persistent pathogens that express Lewisx and Lewisy sequences
suggest that they are likely involved in the induction of tolerance
to the developing human in utero (Garcia-Vallejo and van Kooyk,
2009).
OTHER FACTORS IN SEMINAL PLASMA
A number of other seminal plasma factors display immunosup-
pressive effects in vitro. The primary assay that has been employed
to assess this effect is the inhibition of phytohemagglutinin
(PHA)-induced proliferation of T lymphocytes. Prostasomes are
a group of 40–500 nm membranous vesicles secreted by the
prostate into human semen. Prostasomes inhibit PHA-induced
proliferation by 69% in a dose dependent manner (Kelly et al.,
1991). However, human prostasomes contain galelectin-3, which
could compete with phytohemagglutinin for binding to galactose-
terminated glycans on T cell glycoproteins (Jones et al., 2010), so
it is possible that this effect could involve a simple lectin blockade
rather than a specific immunosuppressive effect. Whether prosta-
somes mediate a specific immunosuppressive effect remains to be
verified.
Still another study indicated that human seminal plasma
components with a MW >3.5 kDa also inhibit PHA-induced
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T lymphocyte proliferation (Ochsenkuhn et al., 2006). While
seminal plasma glycoproteins could also inhibit PHA binding
to T lymphocytes via non-specific lectin blockade, an antibody
directed against TGF-β has been shown to inhibit this immuno-
suppressive activity by 50%, indicating that this specific cytokine
could be partially responsible for this effect (Ochsenkuhn et al.,
2006). The immune deviating effects of seminal plasma glycopro-
teins certainly deserve further attention.
Polyamines in seminal plasma have also been implicated in
the suppression of immune responses in the female reproductive
tract (Allen and Roberts, 1986). Spermine is present in millimo-
lar concentrations in human seminal plasma (Agostinelli et al.,
2007). Supplementation of lymphocyte cultures with spermine
leads to a cytotoxic effect that mimics that seen after addition
of seminal plasma (Allen and Roberts, 1987). Spermine inhibits
LAK cell activity directed against cervical carcinoma cells by up
to 60% at concentrations exceeding 10 nM (Evans et al., 1995).
Although the precise mechanisms underlying this finding remain
unclear, the deamination of spermine by amine oxidases generates
both hydrogen peroxides and aldehydes that promote apoptosis
(Agostinelli et al., 2007).
CONCLUSIONS
Humans have a complex immune system consisting of both
innate and adaptive arms and immune cells have developed intri-
cate means of recognizing each other that involve HLA class I
and class II molecules. Further complexity is introduced by the
diversification of these molecules into many haplotypes to enable
exceptionally precise recognition of self in the immunological
context. However, this diversity may come at a cost, as it makes
the paternal antigen-expressing human fetus the equivalent of
a foreign organ transplant within the immunocompetent gravid
female (Reisner et al., 2011). The maternal immune system can-
not simply be inactivated to allow for reproduction because of the
incumbent risk of infection, particularly that arising in the com-
plex microbiologic milieu of the lower genital tract. A compro-
mise state must therefore be established that will allow selective
immune privilege for gametes and the developing fetus within
the context of an otherwise immunocompetent female repro-
ductive system. A reasonable, though not fully potent, immune
response to pathogens must persist to protect the mother from
infection.
The pathways that promote immune privilege are best under-
stood in the eye (Streilein, 2003; Niederkorn, 2012). Niederkorn
recently proposed an attractive hypothesis that suggests that
metastatic uveal melanoma cells found in the liver have “plagia-
rized” the blueprints employed for ocular immune privilege to
create “ad hoc” immune privileged regions in this distant site
(Niederkorn, 2012). Obviously, there are enormous advantages
for metastatic cells if this hypothesis is correct, as it likely is.
The proposal was made some time ago that a similar type
of immune privilege exists for human gametes and the utero-
placental unit (Clark et al., 1996, 1997). Both SLEX and the
Lewisy carbohydrate sequences were originally defined as tumor-
associated carbohydrate antigens, based on their specific expres-
sion on cancer cells but not on their progenitor cells (Abe et al.,
1983; Fukushima et al., 1984). A recent study has confirmed the
profligate expression of SLEX sequences on the human ZP (Pang
et al., 2011). Lewisy sequences are similarly expressed on human
sperm and seminal plasma glycoproteins (Pang et al., 2007,
2009). The strong possibility exists that pathogens can also hijack
those elements of immune privilege utilized in the reproductive
system of humans to evade the immune response. For exam-
ple, variants of H. pylori that express Lewisx/Lewisy sequences
on their lipopolysaccharides promote tolerance, whereas non-
expressors evoke the severe inflammatory responses that result
in the pathological symptoms associated with this bacterial
pathogen (Bergman et al., 2006). HIV infection substantially
increases the percentage of CD4+ and CD8+ T cells that express
the Lewisy sequence (Adachi et al., 1988; Kashiwagi et al., 1994),
a characteristic that may allow for relatively unfettered viral
proliferation.
It is a substantial challenge to understand how carbohydrate
sequences act as functional groups to mediate immunomodula-
tory effects at the fetomaternal interface. One major obstacle has
been the inability to sequence glycans from small amounts of gly-
coproteins, such as MHC class I molecules. Major advances in
mass spectrometry have recently led to the complete structural
analysis of native human ZP glycans by Dell and coworkers, a
feat performed with only 5μg of purified ZP (Pang et al., 2011).
HLA-G expressed on EVTB is differentially glycosylated when
compared to classical MHC molecules (McMaster et al., 1998).
If HLA-G glycans act as crucial functional groups, then aberrant
glycosylation could result in the pathological effects observed dur-
ing pregnancy. Current molecular and proteomic strategies could
never detect these glycobiological changes.
How the information in such carbohydrate signals is trans-
mitted in immune cells must also be defined. Siglecs usually bear
specific ITIM that mediate immune modulatory effects via con-
ventional signaling mechanisms (Crocker et al., 2007). The two
exceptions (Siglec H and Siglec 14) activate immune cells by
interacting with the membrane protein, DAP12 (Angata et al.,
2006; Blasius et al., 2006). Other C-type lectin-like receptor com-
plexes are also expressed on NK cells, including the CD94/NKG2
family receptors that employ ITIM/ITAM (immunoreceptor
tyrosine-based motif) dependent pathways (Borrego et al., 2006).
Carbohydrate ligands for CD94 and NKG2 have not been defined,
but neither have the glycans associated with naturally occurring
MHC class I molecules that could interact with these lectins.
The effects of galectins are more subtle and complex, because
they can form lattices of different glycoproteins that promote sig-
naling via both lectin-like and protein-protein interactions (Lau
and Dennis, 2008). Since there are many galectins, the potential
for establishing functional pathways by organizing such glyco-
protein complexes on cell surfaces is substantial (Than et al.,
2012).
In summary, these findings suggest that investigation of
the pathways that evoke immune privileged states in humans
could lead to an understanding of the mechanisms that enable
pathogens and tumor cells to evade the immune response. Once
such pathways are defined, they can hopefully be readily tar-
geted for therapeutic intervention. The role of carbohydrate
recognition in such processes is now beginning to be fully
appreciated.
www.frontiersin.org February 2013 | Volume 4 | Article 26 | 9
Clark and Schust Female reproduction and immune privilege
REFERENCES
Abe, K., McKibbin, J. M., and
Hakomori, S. (1983). The mon-
oclonal antibody directed to
difucosylated type 2 chain (Fucα1-
2Galβ1-4[Fucα1-3]GlcNAc; Y
Determinant). J. Biol. Chem. 258,
11793–11797.
Adachi, M., Hayami, M., Kashiwagi, N.,
Mizuta, T., Ohta, Y., Gill, M. J., et al.
(1988). Expression of Ley antigen
in human immunodeficiency virus-
infected human T cell lines and in
peripheral lymphocytes of patients
with acquired immune deficiency
syndrome (AIDS) and AIDS-related
complex (ARC). J. Exp. Med. 167,
323–331.
Agostinelli, E., Tempera, G., Molinari,
A., Salvi,M., Battaglia, V., Toninello,
A., et al. (2007). The physiological
role of biogenic amines redox reac-
tions in mitochondria. New per-
spectives in cancer therapy. Amino
Acids 33, 175–187.
Allen, R. D., and Roberts, T. K.
(1986). The relationship between
the immunosuppressive and cyto-
toxic effects of human seminal
plasma. Am. J. Reprod. Immunol.
Microbiol. 11, 59–64.
Allen, R. D., and Roberts, T. K. (1987).
Role of spermine in the cyto-
toxic effects of seminal plasma. Am.
J. Reprod. Immunol. Microbiol. 13,
4–8.
Aluvihare, V. R., Kallikourdis, M.,
and Betz, A. G. (2004). Regulatory
T cells mediate maternal tolerance
to the fetus. Nat. Immunol. 5,
266–271.
Angata, T., Hayakawa, T., Yamanaka,
M., Varki, A., and Nakamura, M.
(2006). Discovery of Siglec-14, a
novel sialic acid receptor under-
going concerted evolution with
Siglec-5 in primates. FASEB J. 20,
1964–1973.
Angata, T., and Varki, A. (2000).
Cloning, characterization, and phy-
logenetic analysis of siglec-9, a new
member of the CD33-related group
of siglecs. Evidence for co-evolution
with sialic acid synthesis pathways.
J. Biol. Chem. 275, 22127–22135.
Apps, R., Gardner, L., and Moffett, A.
(2008). A critical look at HLA-G.
Trends Immunol. 29, 313–321.
Apps, R., Sharkey, A., Gardner, L.,
Male, V., Kennedy, P., Masters, L.,
et al. (2011). Ex vivo functional
responses to HLA-G differ between
blood and decidual NK cells. Mol.
Hum. Reprod. 17, 577–586.
Arruvito, L., Sanz, M., Banham, A. H.,
and Fainboim, L. (2007). Expansion
of CD4+CD25+and FOXP3+ reg-
ulatory T cells during the follicu-
lar phase of the menstrual cycle:
implications for human reproduc-
tion. J. Immunol. 178, 2572–2578.
Avril, T., Floyd, H., Lopez, F., Vivier,
E., and Crocker, P. R. (2004). The
membrane-proximal immunore-
ceptor tyrosine-based inhibitory
motif is critical for the inhibitory sig-
nalingmediated by Siglecs-7 and -9,
CD33-related Siglecs expressed on
human monocytes and NK cells.
J. Immunol. 173, 6841–6849.
Baban, B., Chandler, P., McCool, D.,
Marshall, B., Munn, D. H., and
Mellor, A. L. (2004). Indoleamine
2, 3-dioxygenase expression is
restricted to fetal trophoblast giant
cells during murine gestation and is
maternal genome specific. J. Reprod.
Immunol. 61, 67–77.
Bankhurst, A. D. (1982). The modu-
lation of human natural killer cell
activity by prostaglandins. J. Clin.
Lab. Immunol. 7, 85–91.
Baratelli, F., Lin, Y., Zhu, L., Yang, S. C.,
Heuze-Vourc’h, N., Zeng, G., et al.
(2005). Prostaglandin E2 induces
FOXP3 gene expression and T regu-
latory cell function in human CD4+
T cells. J. Immunol. 175, 1483–1490.
Baratelli, F. E., Heuze-Vourc’h, N.,
Krysan, K., Dohadwala, M., Riedl,
K., Sharma, S., et al. (2004).
Prostaglandin E2-dependent
enhancement of tissue inhibitors
of metalloproteinases-1 production
limits dendritic cell migration
through extracellular matrix.
J. Immunol. 173, 5458–5466.
Barondes, S. H., Castronovo, V.,
Cooper, D. N., Cummings, R.
D., Drickamer, K., Feizi, T., et al.
(1994). Galectins: a family of animal
beta-galactoside-binding lectins.
Cell 76, 597–598.
Basso, O., Christensen, K., and Olsen, J.
(2001). Higher risk of pre-eclampsia
after change of partner. An effect
of longer interpregnancy intervals?
Epidemiology 12, 624–629.
Bast, R. C. Jr., Feeney, M., Lazarus, H.,
Nadler, L. M., Colvin, R. B., and
Knapp, R. C. (1981). Reactivity of
a monoclonal antibody with human
ovarian carcinoma. J. Clin. Invest.
68, 1331–1337.
Bast, R. C. Jr., Klug, T. L., St. John, E.,
Jenison, E., Niloff, J. M., Lazarus,
H., et al. (1983). A radioimmunoas-
say using a monoclonal antibody
to monitor the course of epithelial
ovarian cancer. N. Engl. J. Med. 309,
883–887.
Beer, A. E., and Billingham, R.
E. (1971). Immunobiology of
mammalian reproduction. Adv.
Immunol. 14, 1–84.
Benirschke, K. (1994). Anatomical rela-
tionship between fetus and mother.
Ann. N.Y. Acad. Sci. 731, 9–20.
Bergman, M., Del Prete, G., van Kooyk,
Y., and Appelmelk, B. (2006).
Helicobacter pylori phase variation,
immune modulation and gastric
autoimmunity. Nat. Rev. Microbiol.
4, 151–159.
Bergmann, C., Strauss, L., Zeidler,
R., Lang, S., and Whiteside, T.
L. (2007). Expansion of human
T regulatory type 1 cells in the
microenvironment of cyclooxyge-
nase 2 overexpressing head and neck
squamous cell carcinoma. Cancer
Res. 67, 8865–8873.
Bian, C. F., Zhang, Y., Sun, H., Li,
D. F., and Wang, D. C. (2011).
Structural basis for distinct binding
properties of the human galectins
to Thomsen-Friedenreich anti-
gen. PLoS ONE 6:e25007. doi:
10.1371/journal.pone.0025007
Blaschitz, A., Juch, H., Volz, A., Hutter,
H., Daxboeck, C., Desoye, G.,
et al. (2005). The soluble pool
of HLA-G produced by human
trophoblasts does not include
detectable levels of the intron
4-containing HLA-G5 and HLA-G6
isoforms. Mol. Hum. Reprod. 11,
699–710.
Blasius, A. L., Cella, M., Maldonado, J.,
Takai, T., and Colonna, M. (2006).
Siglec-H is an IPC-specific receptor
that modulates type I IFN secre-
tion through DAP12. Blood 107,
2474–2476.
Blixt, O., Head, S., Mondala, T.,
Scanlan, C., Huflejt, M. E., Alvarez,
R., et al. (2004). Printed covalent
glycan array for ligand profiling
of diverse glycan binding proteins.
Proc. Natl. Acad. Sci. U.S.A. 101,
17033–17038.
Blois, S. M., Ilarregui, J. M., Tometten,
M., Garcia, M., Orsal, A. S., Cordo-
Russo, R., et al. (2007). A pivotal
role for galectin-1 in fetomaternal
tolerance. Nat. Med. 13, 1450–1457.
Bluestone, J. A., and Tang, Q. (2005).
How do CD4+CD25+ regulatory
T cells control autoimmunity? Curr.
Opin. Immunol. 17, 638–642.
Bohn, H., Kraus, W., and Winckler, W.
(1983). Purification and character-
ization of two new soluble placen-
tal tissue proteins (PP13 and PP17).
Oncodev. Biol. Med. 4, 343–350.
Boniface, K., Bak-Jensen, K. S., Li, Y.,
Blumenschein, W. M., McGeachy,
M. J., McClanahan, T. K., et al.
(2009). Prostaglandin E2 regu-
lates Th17 cell differentiation and
function through cyclic AMP and
EP2/EP4 receptor signaling. J. Exp.
Med. 206, 535–548.
Borrego, F., Masilamani, M., Marusina,
A. I., Tang, X., and Coligan, J. E.
(2006). The CD94/NKG2 family of
receptors: from molecules and cells
to clinical relevance. Immunol. Res.
35, 263–278.
Braun, D., Longman, R. S., and Albert,
M. L. (2005). A two-step induction
of indoleamine 2, 3 dioxygenase
(IDO) activity during dendritic-
cell maturation. Blood 106,
2375–2381.
Burton, G. J., and Jauniaux, E. (2004).
Placental oxidative stress: from mis-
carriage to preeclampsia. J. Soc.
Gynecol. Investig. 11, 342–352.
Carini, C., Hudspith, B. N., and
Brostoff, J. (1981). Effect
of prostaglandins and cyclic
nucleotides on growth and
immunoglobulin secretion of
two IgE myeloma cell lines. Br.
J. Cancer 43, 257–260.
Chazara, O., Xiong, S., and Moffett,
A. (2011). Maternal KIR and fetal
HLA-C: a fine balance. J. Leukoc.
Biol. 90, 703–716.
Chiu, P. C., Chung, M. K., Tsang,
H. Y., Koistinen, R., Koistinen,
H., Seppala, M., et al. (2005).
Glycodelin-S in human semi-
nal plasma reduces cholesterol
efflux and inhibits capacitation of
spermatozoa. J. Biol. Chem. 280,
25580–25589.
Clark, G. F. (2010). The mammalian
zona pellucida: a matrix that
mediates both gamete binding and
immune recognition? Syst. Biol.
Reprod. Med. 56, 349–364.
Clark, G. F., Dell, A., Morris, H.
R., Patankar, M., Oehninger, S.,
and Seppala, M. (1997). Viewing
AIDS from a glycobiological per-
spective: potential linkages to the
human fetoembryonic defence sys-
tem hypothesis. Mol. Hum. Reprod.
3, 5–13.
Clark, G. F., Grassi, P., Pang, P. C.,
Panico, M., Lafrenz, D., Drobnis, E.
Z., et al. (2012). Tumor biomarker
glycoproteins in the seminal plasma
of healthy human males are endoge-
nous ligands for DC-SIGN. Mol.
Cell. Proteomics 11:M111.008730.
doi: 10.1074/mcp.M111.008730
Clark, G. F., Oehninger, S., Patankar, M.
S., Koistinen, R., Dell, A., Morris, H.
R., et al. (1996). A role for glycocon-
jugates in human development: the
human feto- embryonic defence sys-
tem hypothesis. Hum. Reprod. 11,
467–473.
Crocker, P. R., Paulson, J. C., and Varki,
A. (2007). Siglecs and their roles
in the immune system. Nat. Rev.
Immunol. 7, 255–266.
Dalton, C. F., Laird, S. M., Serle,
E., Saravelos, H., Warren, M.
A., Li, T. C., et al. (1995). The
measurement of CA 125 and
placental protein 14 in uterine
flushings in women with recurrent
Frontiers in Immunology | Immunological Tolerance February 2013 | Volume 4 | Article 26 | 10
Clark and Schust Female reproduction and immune privilege
miscarriage; relation to endometrial
morphology. Hum. Reprod. 10,
2680–2684.
Dell, A., Morris, H. R., Easton,
R. L., Panico, M., Patankar,
M., Oehniger, S., et al. (1995).
Structural analysis of the oligosac-
charides derived from glycodelin,
a human glycoprotein with potent
immunosuppressive and contracep-
tive activities. J. Biol. Chem. 270,
24116–24126.
Doyen, V., Rubio, M., Braun, D.,
Nakajima, T., Abe, J., Saito, H.,
et al. (2003). Thrombospondin 1
is an autocrine negative regulator
of human dendritic cell activation.
J. Exp. Med. 198, 1277–1283.
Drake, P. M., Gunn, M. D., Charo, I.
F., Tsou, C. L., Zhou, Y., Huang,
L., et al. (2001). Human placental
cytotrophoblasts attract monocytes
and CD56(bright) natural killer
cells via the actions of monocyte
inflammatory protein 1alpha. J. Exp.
Med. 193, 1199–1212.
Drobnis, E. Z., and Overstreet, J. W.
(1992). Natural history of mam-
malian spermatozoa in the female
reproductive tract. Oxf. Rev. Reprod.
Biol. 14, 1–45.
Dym, M. (1973). The fine structure
of the monkey (Macaca) Sertoli
cell and its role in maintaining the
blood-testis barrier. Anat. Rec. 175,
639–656.
Earle, K. E., Tang, Q., Zhou, X., Liu,
W., Zhu, S., Bonyhadi, M. L., et al.
(2005). In vitro expanded human
CD4+CD25+ regulatory T cells sup-
press effector T cell proliferation.
Clin. Immunol. 115, 3–9.
Easton, R. L., Patankar, M. S., Clark,
G. F., Morris, H. R., and Dell,
A. (2000). Pregnancy-associated
changes in the glycosylation of
Tamm-Horsfall glycoprotein.
Expression of sialyl Lewisx sequence
on core 2 type O-glycans derived
from uromodulin. J. Biol. Chem.
275, 21928–21938.
Esaki, Y., Li, Y., Sakata, D., Yao,
C., Segi-Nishida, E., Matsuoka, T.,
et al. (2010). Dual roles of PGE2-
EP4 signaling in mouse experimen-
tal autoimmune encephalomyelitis.
Proc. Natl. Acad. Sci. U.S.A. 107,
12233–12238.
Evans, C. H., Lee, T. S., and Flugelman,
A. A. (1995). Spermine-directed
immunosuppression of cervical car-
cinoma cell sensitivity to a majority
of lymphokine-activated killer lym-
phocyte cytotoxicity. Nat. Immun.
14, 157–163.
Ewoldsen, M. A., Ostlie, N. S., and
Warner, C. M. (1987). Killing of
mouse blastocyst stage embryos
by cytotoxic T lymphocytes
directed to major histocompatibility
complex antigens. J. Immunol. 138,
2764–2770.
Favier, B., Lemaoult, J., and Carosella,
E. D. (2007a). Functions of HLA-
G in the immune system. Tissue
Antigens 69(Suppl. 1), 150–152.
Favier, B., Lemaoult, J., Rouas-Freiss,
N., Moreau, P., Menier, C., and
Carosella, E. D. (2007b). Research
on HLA-G: an update. Tissue
Antigens 69, 207–211.
Fedder, J. (1996). Nonsperm cells in
human semen: with special refer-
ence to seminal leukocytes and their
possible influence on fertility. Arch.
Androl. 36, 41–65.
Fijak, M., and Meinhardt, A. (2006).
The testis in immune privilege.
Immunol. Rev. 213, 66–81.
Fox, C. A., Meldrum, S. J., and Watson,
B. W. (1973). Continuous measure-
ment by radio-telemetry of vaginal
pH during human coitus. J. Reprod.
Fertil. 33, 69–75.
Foxall, C., Watson, S. R., Dowbenko,
D., Fennie, C., Lasky, L. A., Kiso,
M., et al. (1992). The three mem-
bers of the selectin receptor family
recognize a common carbohydrate
epitope, the sialyl Lewisx oligosac-
charide. J. Cell Biol. 117, 895–902.
Fukuda, M., Hiraoka, N., and Yeh, J.
C. (1999). C-type lectins and sialyl
Lewis X oligosaccharides. Versatile
roles in cell-cell interaction. J. Cell
Biol. 147, 467–470.
Fukushima, K., Hirota, M., Terasaki, P.
I., Wakisaka, A., Togashi, H., Chia,
D., et al. (1984). Characterization of
sialosylated Lewisx as a new tumor-
associated antigen. Cancer Res. 44,
5279–5285.
Garcia-Vallejo, J. J., and van Kooyk,
Y. (2009). Endogenous ligands for
C-type lectin receptors: the true
regulators of immune homeostasis.
Immunol. Rev. 230, 22–37.
Georgiades, P., Ferguson-Smith, A.
C., and Burton, G. J. (2002).
Comparative developmental
anatomy of the murine and human
definitive placentae. Placenta 23,
3–19.
Ghiringhelli, F., Menard, C., Martin, F.,
and Zitvogel, L. (2006). The role of
regulatory T cells in the control of
natural killer cells: relevance during
tumor progression. Immunol. Rev.
214, 229–238.
Goldblatt, M. W. (1935). Properties of
human seminal plasma. J. Physiol.
84, 208–218.
Gomi, K., Zhu, F. G., and Marshall, J.
S. (2000). Prostaglandin E2 selec-
tively enhances the IgE-mediated
productin of IL-6 and granulocyte-
macrophase colony-stimulating
factor by mast cells through an
EP1/EP3-dependent mechanism.
J. Immunol. 165, 6545–6552.
Goto, T., Herberman, R. B., Maluish,
A., and Strong, D. M. (1983).
Cyclic AMP as a mediator of
prostaglandin E-induced sup-
pression of human natural killer
cell activity. J. Immunol. 130,
1350–1355.
Grinnell, B. W., Hermann, R. B., and
Yan, S. B. (1994). Human pro-
tein C inhibits selectin-mediated
cell adhesion: role of unique fucosy-
lated oligosaccharide. Glycobiology
4, 221–225.
Gubbels, J. A., Felder, M., Horibata,
S., Belisle, J. A., Kapur, A., Holden,
H., et al. (2010). MUC16 provides
immune protection by inhibiting
synapse formation between NK and
ovarian tumor cells. Mol. Cancer
9:11. doi: 10.1186/1476-4598-9-11
Gupta, S. K., Mountain, L., and
Alexander, N. J. (1988). Seminal
plasma antigens detected by
immunoblotting with human sera
from vasectomized males. J. Reprod.
Immunol. 12, 263–276.
Gustafsson, K., Ingelsten, M., Bergqvist,
L., Nystrom, J., Andersson, B.,
and Karlsson-Parra, A. (2008).
Recruitment and activation of nat-
ural killer cells in vitro by a human
dendritic cell vaccine. Cancer Res.
68, 5965–5971.
He, J., and Baum, L. G. (2006).
Endothelial cell expression of
galectin-1 induced by prostate
cancer cells inhibits T-cell
transendothelial migration. Lab.
Invest. 86, 578–590.
Head, J. R., and Billingham, R. E.
(1985). Immunologically privileged
sites in transplantation immunol-
ogy and oncology. Perspect. Biol.
Med. 29, 115–131.
Hession, C., Decker, J. M., Sherblom,
A. P., Kumar, S., Yue, C. C.,
Mattaliano, R. J., et al. (1987).
Uromodulin (Tamm-Horsfall gly-
coprotein): a renal ligand for lym-
phokines. Science 237, 1479–1484.
Heusinkveld, M., de Vos van
Steenwijk, P. J., Goedemans, R.,
Ramwadhdoebe, T. H., Gorter,
A., Welters, M. J., et al. (2011).
M2 macrophages induced by
prostaglandin E2 and IL-6 from
cervical carcinoma are switched
to activated M1 macrophages by
CD4+ Th1 cells. J. Immunol. 187,
1157–1165.
Hu, Z. Q., Asano, K., Seki, H., and
Shimanura, T. (1995). An essential
role of prostaglandin E on mouse
mast cell induction. J. Immunol.
155, 2134–2142.
Huang, M., Stolina, M., Sharma, S.,
Mao, J. T., Zhu, L., Miller, P. W.,
et al. (1998). Non-small cell lung
cancer cyclooxygenase-2-dependent
regulation of cytokine balance in
lymphocytes and macrophages:
up-regulation of interleukin 10
and down-regulation of interleukin
12 production. Cancer Res. 58,
1208–1216.
Hubbard, L. L., Ballinger, M. N.,
Thomas, P. E., Wilke, C. A.,
Standiford, T. J., Kobayashi, K.
S., et al. (2010). A role for IL-
1 receptor-associated kinase-M
in prostaglandin E2-induced
immunosuppression post-
bone marrow transplantation.
J. Immunol. 184, 6299–6308.
Hunt, J. S. (2006). Stranger in a
strange land. Immunol. Rev. 213,
36–47.
Hutter, H., and Dohr, G. (1998).
HLA expression on immature and
mature human germ cells. J. Reprod.
Immunol. 38, 101–122.
Hutter, H., Hammer, A., Blaschitz, A.,
Hartmann, M., Ebbesen, P., Dohr,
G., et al. (1996). Expression of
HLA class I molecules in human
first trimester and term placenta
trophoblast. Cell Tissue Res. 286,
439–447.
Ilarregui, J. M., Croci, D. O., Bianco,
G. A., Toscano, M. A., Salatino, M.,
Vermeulen, M. E., et al. (2009).
Tolerogenic signals delivered by
dendritic cells to T cells through
a galectin-1-driven immunoregula-
tory circuit involving interleukin 27
and interleukin 10. Nat. Immunol.
10, 981–991.
Ish-Shalom, E., Gargir, A., Andre,
S., Borovsky, Z., Ochanuna,
Z., Gabius, H. J., et al. (2006).
alpha2, 6-Sialylation promotes
binding of placental protein 14
via its Ca2+-dependent lectin
activity: insights into differ-
ential effects on CD45RO and
CD45RA T cells. Glycobiology 16,
173–183.
Jeschke, U., Wang, X., Briese, V., Friese,
K., and Stahn, R. (2003). Glycodelin
and amniotic fluid transferrin as
inhibitors of E-selectin-mediated
cell adhesion. Histochem. Cell Biol.
119, 345–354.
Jones, J. L., Saraswati, S., Block, A. S.,
Lichti, C. F., Mahadevan, M., and
Diekman, A. B. (2010). Galectin-
3 is associated with prostasomes
in human semen. Glycoconj. J. 27,
227–236.
Jonuleit, H., Kuhn, U., Muller, G.,
Steinbrink, K., Paragnik, L.,
Schmitt, E., et al. (1997). Pro-
inflammatory cytokines and
prostaglandins induce maturation
of potent immunostimulatory
dendritic cells under fetal calf
www.frontiersin.org February 2013 | Volume 4 | Article 26 | 11
Clark and Schust Female reproduction and immune privilege
serum-free conditions. Eur.
J. Immunol. 27, 3135–3142.
Joshi, P. C., Zhou, X., Cuchens, M., and
Jones, Q. (2001). Prostaglandin E2
suppressed IL-15-mediated human
NK cell function through down-
regulation of common gamma-
chain. J. Immunol. 166, 885–891.
Juch, H., Blaschitz, A., Dohr, G.,
and Hutter, H. (2012). HLA class
I expression in the human pla-
centa. Wien. Med. Wochenschr. 162,
196–200.
Julkunen, M., Rutanen, E. M.,
Koskimies, A., Ranta, T., Bohn,
H., and Seppala, M. (1985).
Distribution of placental protein 14
in tissues and body fluids during
pregnancy. Br. J. Obstet. Gynaecol.
92, 1145–1151.
Kalin´ski, P., Hilkens, C. M., Snijders, A.,
Snijdewint, F. G., and Kapsenberg,
M. L. (1997). IL-12-deficient
dendritic cells, generated in the
presence of prostaglandin E2, pro-
mote type 2 cytokine production
in maturing human naive T helper
cells. J. Immunol. 159, 28–35.
Kalin´ski, P., Hilkens, C. M., Wierenga,
E. A., and Kapsenberg, M. L.
(1999). T-cell priming by type-1
and type-2 polarized dendritic
cells: the concept of a third
signal. Immunol. Today 20,
561–567.
Kalin´ski, P., Schuitemaker, J. H.,
Hilkens, C. M., and Kapsenberg,
M. L. (1998). Prostaglandin E2
induces the final maturation of
IL-12-deficient CD1a+CD83+
dendritic cells: the levels of IL-12
are determined during the final
dendritic cell maturation and are
resistant to further modulation.
J. Immunol. 161, 2804–2809.
Kamimura, S., Eguchi, K., Yonezawa,
M., and Sekiba, K. (1991).
Localization and developmental
change of indoleamine 2, 3-
dioxygenase activity in the human
placenta. Acta Med. Okayama 45,
135–139.
Karre, K. (1991). MHC gene control of
the natural killer system at the level
of the target and the host. Semin.
Cancer Biol. 2, 295–309.
Kashiwagi, N., Gill, M. J., Adachi,
M., Church, D., Wong, S. J., Poon,
M. C., et al. (1994). Lymphocyte
membrane modifications induced
by HIV infection. Tohoku J. Exp.
Med. 173, 115–131.
Kelly, R. W., Holland, P., Skibinski,
G., Harrison, C., McMillan,
L., Hargreave, T., et al. (1991).
Extracellular organelles (prosta-
somes) are immunosuppressive
components of human semen. Clin.
Exp. Immunol. 86, 550–556.
Kelly, R. W., Taylor, P. L., Hearn,
J. P., Short, R. V., Martin, D.
E., and Marston, J. H. (1976).
19-Hydroxyprostaglandin E1 as a
major component of the semen of
primates. Nature 260, 544–545.
Kho, E. M., McCowan, L. M., North,
R. A., Roberts, C. T., Chan, E.,
Black, M. A., et al. (2009). Duration
of sexual relationship and its effect
on preeclampsia and small for
gestational age perinatal outcome.
J. Reprod. Immunol. 82, 66–73.
King, A., Allan, D. S., Bowen, M.,
Powis, S. J., Joseph, S., Verma, S.,
et al. (2000). HLA-E is expressed
on trophoblast and interacts with
CD94/NKG2 receptors on decid-
ual NK cells. Eur. J. Immunol. 30,
1623–1631.
King, A., Birkby, C., and Loke, Y.
W. (1989). Early human decidual
cells exhibit NK activity against
the K562 cell line but not against
first trimester trophoblast. Cell.
Immunol. 118, 337–344.
King, A., Burrows, T., and Loke, Y.
W. (1996). Human uterine natural
killer cells. Nat. Immun. 15, 41–52.
King, A., Burrows, T., Verma, S., Hiby,
S., and Loke, Y. W. (1998). Human
uterine lymphocytes. Hum. Reprod.
Update 4, 480–485.
King, A., and Loke, Y. W. (1990).
Human trophoblast and JEG chori-
ocarcinoma cells are sensitive to
lysis by IL-2-stimulated decidual
NK cells. Cell. Immunol. 129,
435–448.
Krensky, A. M., Weiss, A., Crabtree,
G., Davis, M. M., and Parham,
P. (1990). T-lymphocyte-antigen
interactions in transplant rejection.
N. Engl. J. Med. 322, 510–517.
Kui Wong, N., Easton, R. L., Panico,
M., Sutton-Smith, M., Morrison,
J. C., Lattanzio, F. A., et al. (2003).
Characterization of the oligosac-
charides associated with the human
ovarian tumor marker CA125.
J. Biol. Chem. 278, 28619–28634.
Kuo, P. L., Hung, J. Y., Huang, S.
K., Chou, S. H., Cheng, D. E.,
Jong, Y. J., et al. (2011). Lung
cancer-derived galectin-1 medi-
ates dendritic cell anergy through
inhibitor of DNA binding 3/IL-10
signaling pathway. J. Immunol. 186,
1521–1530.
Lala, P. K., Kennedy, T. G., and Parhar,
R. S. (1988). Suppression of lym-
phocyte alloreactivity by early
gestational human decidua. II.
Characterization of the suppressor
mechanisms. Cell. Immunol. 116,
411–422.
Lau, K. S., and Dennis, J. W. (2008).
N-Glycans in cancer progression.
Glycobiology 18, 750–760.
Lee, C. L., Lam, E. Y., Lam, K. K.,
Koistinen, H., Seppala, M., Ng,
E. H., et al. (2012). Glycodelin-A
stimulates interleukin-6 secre-
tion by human monocytes and
macrophages through L-selectin
and the extracellular signal-
regulated kinase pathway. J. Biol.
Chem. 287, 36999–37009.
Lee, C. L., Pang, P. C., Yeung, W. S.,
Tissot, B., Panico, M., Lao, T. T.,
et al. (2009). Effects of differential
glycosylation of glycodelins on lym-
phocyte survival. J. Biol. Chem. 284,
15084–15096.
Leibovitz, A., Baumoehl, Y., and Segal,
R. (2004). Increased incidence of
pathological and clinical prostate
cancer with age: age related alter-
ations of local immune surveillance.
J. Urol. 172, 435–437.
Li, N., Wang, T., and Han, D. (2012).
Structural, cellular and molecular
aspects of immune privilege in the
testis. Front. Immun. 3:152. doi:
10.3389/fimmu.2012.00152
Lombardo, F., Gandini, L., Dondero,
F., and Lenzi, A. (2001). Antisperm
immunity in natural and assisted
reproduction. Hum. Reprod. Update
7, 450–456.
Luft, T., Jefford, M., Luetjens, P.,
Toy, T., Hochrein, H., Masterman,
K. A., et al. (2002). Functionally
distinct dendritic cell (DC) popula-
tions induced by physiologic stim-
uli: prostaglandin E(2) regulates the
migratory capacity of specific DC
subsets. Blood 100, 1362–1372.
Maegawa, M., Kamada, M., Irahara, M.,
Yamamoto, S., Yoshikawa, S., Kasai,
Y., et al. (2002). A repertoire of
cytokines in human seminal plasma.
J. Reprod. Immunol. 54, 33–42.
Mailliard, R. B., Alber, S. M., Shen,
H., Watkins, S. C., Kirkwood, J.
M., Herberman, R. B., et al. (2005).
IL-18-induced CD83+CCR7+ NK
helper cells. J. Exp. Med. 202,
941–953.
McIlroy, A., Caron, G., Blanchard, S.,
Fremaux, I., Duluc, D., Delneste,
Y., et al. (2006). Histamine and
prostaglandin E up-regulate the
production of Th2-attracting
chemokines (CCL17 and CCL22)
and down-regulate IFN-gamma-
induced CXCL10 production by
immature human dendritic cells.
Immunology 117, 507–516.
McMaster, M., Zhou, Y., Shorter, S.,
Kapasi, K., Geraghty, D., Lim, K. H.,
et al. (1998). HLA-G isoforms pro-
duced by placental cytotrophoblasts
and found in amniotic fluid are
due to unusual glycosylation.
J. Immunol. 160, 5922–5928.
Medawar, P. (1953). Some immunolog-
ical and endocrinological problems
raised by the evolution of viviparity
in vertebrates. Symp. Soc. Exp. Biol.
7, 320–338.
Meekins, J. W., Luckas, M. J.,
Pijnenborg, R., and McFadyen,
I. R. (1997). Histological study
of decidual spiral arteries and the
presence of maternal erythrocytes
in the intervillous space during the
first trimester of normal human
pregnancy. Placenta 18, 459–464.
Morris, H. R., Dell, A., Easton, R.
L., Panico, M., Koistinen, H.,
Koistinen, R., et al. (1996). Gender-
specific glycosylation of human
glycodelin affects its contracep-
tive activity. J. Biol. Chem. 271,
32159–32167.
Motran, C. C., Molinder, K. M., Liu,
S. D., Poirier, F., and Miceli, M.
C. (2008). Galectin-1 functions
as a Th2 cytokine that selec-
tively induces Th1 apoptosis and
promotes Th2 function. Eur.
J. Immunol. 38, 3015–3027.
Mukhopadhyay, D., Sundereshan, S.,
Rao, C., and Karande, A. A. (2001).
Placental protein 14 induces apop-
tosis in T cells but not inmonocytes.
J. Biol. Chem. 276, 28268–28273.
Muldoon, L. L., Alvarez, J. I., Begley,
D. J., Boado, R. J., Del Zoppo, G.
J., Doolittle, N. D., et al. (2013).
Immunologic privilege in the cen-
tral nervous system and the blood-
brain barrier. J. Cereb. Blood Flow
Metab. 33, 13–21.
Munn, D. H., and Armstrong, E.
(1993). Cytokine regulation of
human monocyte differentiation
in vitro: the tumor-cytotoxic phe-
notype induced by macrophage
colony-stimulating factor is
developmentally regulated by
gamma-interferon. Cancer Res. 53,
2603–2613.
Munn, D. H., Zhou, M., Attwood,
J. T., Bondarev, I., Conway, S.
J., Marshall, B., et al. (1998).
Prevention of allogeneic fetal rejec-
tion by tryptophan catabolism
Science 281, 1191–1193.
Muthuswamy, R., Mueller-Berghaus, J.,
Haberkorn, U., Reinhart, T. A.,
Schadendorf, D., and Kalinski, P.
(2010). PGE2 transiently enhances
DC expression of CCR7 but inhibits
the ability of DCs to produce CCL19
and attract naive T cells. Blood 116,
1454–1459.
Muthuswamy, R., Urban, J., Lee, J. J.,
Reinhart, T. A., Bartlett, D., and
Kalinski, P. (2008). Ability of mature
dendritic cells to interact with reg-
ulatory T cells is imprinted dur-
ing maturation. Cancer Res. 68,
5972–5978.
Nakayama, T., Mutsuga, N., Yao, L., and
Tosato, G. (2006). Prostaglandin
Frontiers in Immunology | Immunological Tolerance February 2013 | Volume 4 | Article 26 | 12
Clark and Schust Female reproduction and immune privilege
E2 promotes degranulation-
independent release of MCP-1
from mast cells. J. Leukoc. Biol. 79,
95–104.
Neaves, W. B., and Billingham, R. E.
(1979). The lymphatic drainage of
the rat prostate and its status as
an immunologically privileged site.
Transplantation 27, 127–132.
Niederkorn, J. Y. (2012). Ocular
immune privilege and ocular
melanoma: parallel universes
or immunological plagia-
rism? Front. Immun. 3:148. doi:
10.3389/fimmu.2012.00148
Nocera, M., and Chu, T. M. (1993).
Transforming growth factor beta
as an immunosuppressive protein
in human seminal plasma. Am.
J. Reprod. Immunol. 30, 1–8.
Nocera, M., and Chu, T. M. (1995).
Characterization of latent trans-
forming growth factor-beta from
human seminal plasma. Am.
J. Reprod. Immunol. 33, 282–291.
Norling, L. V., Sampaio, A. L., Cooper,
D., and Perretti, M. (2008).
Inhibitory control of endothelial
galectin-1 on in vitro and in vivo
lymphocyte trafficking. FASEB J.
22, 682–690.
North, S. J., Hitchen, P. G., Haslam, S.
M., and Dell, A. (2009). Mass spec-
trometry in the analysis of N-linked
and O-linked glycans. Curr. Opin.
Struct. Biol. 19, 498–506.
Obermajer, N., Muthuswamy, R.,
Lesnock, J., Edwards, R. P., and
Kalinski, P. (2011). Positive feed-
back between PGE2 and COX2
redirects the differentiation of
human dendritic cells toward stable
myeloid-derived suppressor cells.
Blood 118, 5498–5505.
Ochsenkuhn, R., O’Connor, A. E.,
Hirst, J. J., Gordon Baker, H. W., De
Kretser, D. M., and Hedger, M. P.
(2006). The relationship between
immunosuppressive activity and
immunoregulatory cytokines in
seminal plasma: influence of sperm
autoimmunity and seminal leuko-
cytes. J. Reprod. Immunol. 71,
57–74.
Okamoto, N., Uchida, A., Takakura, K.,
Kariya, Y., Kanzaki, H., Riittinen, L.,
et al. (1991). Suppression by human
placental protein 14 of natural killer
cell activity.Am. J. Reprod. Immunol.
26, 137–142.
Pandya, I. J., and Cohen, J. (1985). The
leukocytic reaction of the human
uterine cervix to spermatozoa.
Fertil. Steril. 43, 417–421.
Pang, P. C., Chiu, P. C., Lee, C. L.,
Chang, L. Y., Panico, M., Morris,
H. R., et al. (2011). Human
sperm binding is mediated by the
sialyl-Lewisx oligosaccharide on
the zona pellucida. Science 333,
1761–1764.
Pang, P. C., Tissot, B., Drobnis, E. Z.,
Morris, H. R., Dell, A., and Clark,
G. F. (2009). Analysis of the human
seminal plasma glycome reveals
the presence of immunomodu-
latory carbohydrate functional
groups. J. Proteome Res. 8,
4906–4915.
Pang, P. C., Tissot, B., Drobnis, E. Z.,
Sutovsky, P., Morris, H. R., Clark, G.
F., et al. (2007). Expression of bisect-
ing type and Lewisx/Lewisy termi-
nated N-glycans on human sperm.
J. Biol. Chem. 282, 36593–36602.
Parhar, R. S., and Lala, P. K. (1988).
Prostaglandin E2-mediated inac-
tivation of various killer lineage
cells by tumor-bearing host
macrophages. J. Leukoc. Biol. 44,
474–484.
Patankar, M. S., Yu, J., Morrison, J. C.,
Belisle, J. A., Lattanzio, F. A., Deng,
Y., et al. (2005). Potent suppres-
sion of natural killer cell response
mediated by the ovarian tumor
marker CA125. Gynecol. Oncol. 99,
704–713.
Pennington, K. A., Schlitt, J. M.,
Jackson, D. L., Schulz, L. C., and
Schust, D. J. (2012). Preeclampsia:
multiple approaches for a multifac-
torial disease. Dis. Model. Mech. 5,
9–18.
Perillo, N. L., Pace, K. E., Seilhamer, J. J.,
and Baum, L. G. (1995). Apoptosis
of T cells mediated by galectin-1.
Nature 378, 736–739.
Pockley, A. G., and Bolton, A. E.
(1989). Placental protein 14
(PP14) inhibits the synthesis of
interleukin-2 and the release of
soluble interleukin-2 receptors from
phytohaemagglutinin-stimulated
lymphocytes. Clin. Exp. Immunol.
77, 252–256.
Pockley, A. G., Mowles, E. A., Stoker,
R. J., Westwood, O. M., Chapman,
M. G., and Bolton, A. E. (1988).
Suppression of in vitro lymphocyte
reactivity to phytohemagglutinin by
placental protein 14. J. Reprod.
Immunol. 13, 31–39.
Rajagopalan, S., and Long, E. O.
(1999). A human histocompatibility
leukocyte antigen (HLA)-G-specific
receptor expressed on all natu-
ral killer cells. J. Exp. Med. 189,
1093–1100.
Reisner, Y., Hagin, D., and Martelli,
M. F. (2011). Haploidentical
hematopoietic transplantation: cur-
rent status and future perspectives.
Blood 118, 6006–6017.
Rieser, C., Bock, G., Klocker, H.,
Bartsch, G., and Thurnher, M.
(1997). Prostaglandin E2 and tumor
necrosis factor alpha cooperate to
activate human dendritic cells: syn-
ergistic activation of interleukin
12 production. J. Exp. Med. 186,
1603–1608.
Rumke, P., and Hellinga, G. (1959).
Autoantibodies against spermato-
zoa in sterile men. Am. J. Clin.
Pathol. 32, 357–363.
Saari, T., Jahnukainen, K.,
and Pollanen, P. (1996).
Autoantigenicity of the basal com-
partment of seminiferous tubules
in the rat. J. Reprod. Immunol. 31,
65–79.
Samuelsson, B. (1963). Isolation and
identification of prostaglandins
from human seminal plasma. 18.
prostaglandins and related factors.
J. Biol. Chem. 238, 3229–3234.
Sargent, I. L. (2005). Does ‘soluble’
HLA-G really exist? Another twist
to the tale. Mol. Hum. Reprod. 11,
695–698.
Sasaki, Y., Sakai, M., Miyazaki, S.,
Higuma, S., Shiozaki, A., and Saito,
S. (2004). Decidual and periph-
eral blood CD4+CD25+ regula-
tory T cells in early pregnancy
subjects and spontaneous abor-
tion cases. Mol. Hum. Reprod. 10,
347–353.
Scandella, E., Men, Y., Gillessen, S.,
Forster, R., and Groettrup, M.
(2002). Prostaglandin E2 is a key
factor for CCR7 surface expression
and migration of monocyte-
derived dendritic cells. Blood 100,
1354–1361.
Setchell, B. P. (1967). The blood-
testicular fluid barrier in sheep.
J. Physiol. 189, 63P–65P.
Sharkey, D. J., Macpherson, A. M.,
Tremellen, K. P.,Mottershead, D. G.,
Gilchrist, R. B., and Robertson, S. A.
(2012a). TGF-beta mediates proin-
flammatory seminal fluid signaling
in human cervical epithelial cells.
J. Immunol. 189, 1024–1035.
Sharkey, D. J., Tremellen, K. P., Jasper,
M. J., Gemzell-Danielsson, K., and
Robertson, S. A. (2012b). Seminal
fluid induces leukocyte recruit-
ment and cytokine and chemokine
mRNA expression in the human
cervix after coitus. J. Immunol. 188,
2445–2454.
Sheibanie, A. F., Yen, J. H., Khayrullina,
T., Emig, F., Zhang, M., Tuma, R.,
et al. (2007). The proinflammatory
effect of prostaglandin E2 in experi-
mental inflammatory bowel disease
is mediated through the IL-23→IL-
17 axis. J. Immunol. 178, 8138–8147.
Shima, T., Sasaki, Y., Itoh, M.,
Nakashima, A., Ishii, N., Sugamura,
K., et al. (2010). Regulatory T cells
are necessary for implantation and
maintenance of early pregnancy but
not late pregnancy in allogeneic
mice. J. Reprod. Immunol. 85,
121–129.
Simkin, N. J., Jelinek, D. F., and Lipsky,
P. E. (1987). Inhibition of human B
cell responsiveness by prostaglandin
E2. J. Immunol. 138, 1074–1081.
Smith, R. J. (1977). Modulation of
phagocytosis by and lysosomal
enzyme secretion from guinea-pig
neutrophils: effect of nonsteroid
anti-inflammatory agents and
prostaglindins. J. Pharmacol. Exp.
Ther. 200, 647–657.
Specht, C., Bexten, S., Kolsch,
E., and Pauels, H. G. (2001).
Prostaglandins, but not tumor-
derived IL-10, shut down
concomitant tumor-specific CTL
responses during murine plasmacy-
toma progression. Int. J. Cancer 91,
705–712.
Stock, A., Booth, S., and Cerundolo, V.
(2011). Prostaglandin E2 suppresses
the differentiation of retinoic acid-
producing dendritic cells in mice
and humans. J. Exp. Med. 208,
761–773.
Stolina, M., Sharma, S., Lin, Y.,
Dohadwala, M., Gardner, B., Luo, J.,
et al. (2000). Specific inhibition of
cyclooxygenase 2 restores antitumor
reactivity by altering the balance
of IL-10 and IL-12 synthesis.
J. Immunol. 164, 361–370.
Stowell, S. R., Karmakar, S., Stowell,
C. J., Dias-Baruffi, M., McEver, R.
P., and Cummings, R. D. (2007).
Human galectin-1, -2, and -4
induce surface exposure of phos-
phatidylserine in activated human
neutrophils but not in activated
T cells. Blood 109, 219–227.
Streilein, J. W. (1995). Unraveling
immune privilege. Science 270,
1158–1159.
Streilein, J. W. (2003). Ocular immune
privilege: therapeutic opportunities
from an experiment of nature. Nat.
Rev. Immunol. 3, 879–889.
Sublett, J. W., and Bernstein, J. A.
(2011). Seminal plasma hypersensi-
tivity reactions: an updated review.
Mt. Sinai J. Med. 78, 803–809.
Tamm, I., and Horsfall, F. L. (1950).
Characterization and separation of
an inhibitor of viral hemagglutina-
tion present in urine. Proc. Soc. Exp.
Biol. Med. 74, 108–114.
Taylor, P. L., and Kelly, R. W. (1974).
19-Hydroxylated E prostaglandins
as the major prostaglandins
of human semen. Nature 250,
665–667.
Templeton, A. A., Cooper, I., and Kelly,
R.W. (1978). Prostaglandin concen-
trations in the semen of fertile men.
J. Reprod. Fertil. 52, 147–150.
Than, N. G., Romero, R., Kim, C. J.,
McGowen, M. R., Papp, Z., and
www.frontiersin.org February 2013 | Volume 4 | Article 26 | 13
Clark and Schust Female reproduction and immune privilege
Wildman, D. E. (2012). Galectins:
guardians of eutherian pregnancy at
the maternal-fetal interface. Trends
Endocrinol. Metab. 23, 23–31.
Thompson, L. A., Barratt, C. L.,
Bolton, A. E., and Cooke, I. D.
(1992). The leukocytic reaction of
the human uterine cervix. Am.
J. Reprod. Immunol. 28, 85–89.
Tirado-Gonzalez, I., Freitag, N.,
Barrientos, G., Shaikly, V., Nagaeva,
O., Strand, M., et al. (2013).
Galectin-1 influences trophoblast
immune evasion and emerges as a
predictive factor for the outcome of
pregnancy. Mol. Hum. Reprod. 19,
43–53.
Tirado-Gonzalez, I., Munoz-
Fernandez, R., Prados, A.,
Leno-Duran, E., Martin, F.,
Abadia-Molina, A. C., et al.
(2012). Apoptotic DC-SIGN+ cells
in normal human decidua. Placenta
33, 257–263.
Toscano, M. A., Bianco, G. A., Ilarregui,
J. M., Croci, D. O., Correale, J.,
Hernandez, J. D., et al. (2007).
Differential glycosylation of TH1,
TH2 and TH-17 effector cells selec-
tively regulates susceptibility to cell
death. Nat. Immunol. 8, 825–834.
Tung, K. S., Teuscher, C., and Meng,
A. L. (1981). Autoimmunity to sper-
matozoa and the testis. Immunol.
Rev. 55, 217–255.
van der Pouw Kraan, T. C., Boeije, L.
C., Smeenk, R. J., Wijdenes, J., and
Aarden, L. A. (1995). Prostaglandin-
E2 is a potent inhibitor of human
interleukin 12 production. J. Exp.
Med. 181, 775–779.
van Dooremaal, J. C. (1873). Die
Entwicklung der in fremden
Grund versetzten lebenden
Geweba. Albrecht von Graefes
Arch. Ophthalmol. 19, 358–373.
van Liempt, E., Bank, C. M., Mehta,
P., Garcia-Vallejo, J. J., Kawar, Z. S.,
Geyer, R., et al. (2006). Specificity of
DC-SIGN for mannose- and fucose-
containing glycans. FEBS Lett. 580,
6123–6131.
von Euler, U. (1935). Über die
Spezifische Blutdrucksenkende
Substanz des Menschlichen
Prostata- und Samenblasensekretes.
Wien Klin Wochenschr 14,
1182–1183.
von Euler, U. S. (1936). On the spe-
cific vasodilating and plain mus-
cle stimulating substances from the
accessory genital glands in man and
certain animals (prostaglandins and
vesiglandin). J. Physiol. (Lond.) 88,
213–234.
Wakefield, L. M., Smith, D. M.,
Masui, T., Harris, C. C., and
Sporn, M. B. (1987). Distribution
and modulation of the cellular
receptor for transforming growth
factor-beta. J. Cell Biol. 105,
965–975.
Walker, C., Kristense, F., Bettens,
F., and Deweck, A. L. (1983).
Lymphokine regulation of activated
(G1) lymphocytes, I: prostaglandin
E2-induced inhibition of inter-
leukin 2 production. J. Immunol.
130, 1770–1773.
Walker, W., and Rotondo, D. (2004).
Prostaglandin E2 is a potent
regulator of interleukin-12- and
interleukin-18-induced natu-
ral killer cell interferon-gamma
synthesis. Immunology 111,
298–305.
Watchmaker, P. B., Berk, E.,
Muthuswamy, R., Mailliard, R.
B., Urban, J. A., Kirkwood, J. M.,
et al. (2010). Independent regula-
tion of chemokine responsiveness
and cytolytic function versus CD8+
T cell expansion by dendritic cells.
J. Immunol. 184, 591–597.
Weller, C. L., Collington, S. J., Hartnell,
A., Conroy, D. M., Kaise, T., Barker,
J. E., et al. (2007). Chemotactic
action of prostaglandin E2 on
mouse mast cells acting via the
PGE2 receptor 3. Proc. Natl. Acad.
Sci. U.S.A. 104, 11712–11717.
Woolard, M. D., Hensley, L. L.,
Kawula, T. H., and Frelinger, J.
A. (2008). Respiratory Francisella
tularensis live vaccine strain
infection induces Th17 cells and
prostaglandin E2, which inhibits
generation of gamma interferon-
positive T cells. Infect. Immun. 76,
2651–2659.
Wu, C. Y., Wang, K., McDyer, J. F., and
Seder, R. A. (1998). Prostaglandin
E2 and dexamethasone inhibit IL-
12 receptor expression and IL-12
responsiveness. J. Immunol. 161,
2723–2730.
Yaniv, E., Borovsky, Z., Mishan-
Eisenberg, G., and Rachmilewitz,
J. (2003). Placental protein 14
regulates selective B cell responses.
Cell. Immunol. 222, 156–163.
Yin, B. W., Dnistrian, A., and Lloyd, K.
O. (2002). Ovarian cancer antigen
CA125 is encoded by the MUC16
mucin gene. Int. J. Cancer 98,
737–740.
Yu, Y., and Chadee, K. (1998).
Prostaglandin E2 stimulates IL-
8 gene expression in human colonic
epithelial cells by a posttranscrip-
tional mechanism. J. Immunol. 161,
3746–3752.
Yule, T. D., Montoya, G. D., Russell,
L. D., Williams, T. M., and Tung,
K. S. (1988). Autoantigenic germ
cells exist outside the blood
testis barrier. J. Immunol. 141,
1161–1167.
Zinkernagel, R. M., and Doherty, P.
C. (1974). Restriction of in vitro
T cell-mediated cytotoxicity in
lymphocytic choriomeningitis
within a syngeneic or semial-
logeneic system. Nature 248,
701–702.
Conflict of Interest Statement: The
authors declare that the research
was conducted in the absence of any
commercial or financial relationships
that could be construed as a potential
conflict of interest.
Received: 07 December 2012; paper
pending published: 21 December 2012;
accepted: 22 January 2013; published
online: 13 February 2013.
Citation: Clark GF and Schust DJ
(2013) Manifestations of immune toler-
ance in the human female reproductive
tract. Front. Immun. 4:26. doi: 10.3389/
fimmu.2013.00026
This article was submitted to Frontiers in
Immunological Tolerance, a specialty of
Frontiers in Immunology.
Copyright © 2013 Clark and Schust.
This is an open-access article dis-
tributed under the terms of the Creative
Commons Attribution License, which
permits use, distribution and repro-
duction in other forums, provided
the original authors and source are
credited and subject to any copyright
notices concerning any third-party
graphics etc.
Frontiers in Immunology | Immunological Tolerance February 2013 | Volume 4 | Article 26 | 14
